Stock listing

Paradigm Biopharmaceuticals Ltd.

Selected listing: PAR · ASX · AUD · AU

Paradigm Biopharmaceuticals Ltd. (ASX:PAR), Health Technology. Latest release Sep 30, 2026: Continuation of Suspension from Quotation.

PAR:ASXAUDAUUpdated October 2, 2026

Ticker: ASX:PAR
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Generic
Exchange: ASX
Currency: AUD

About Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. is a public company listed on the Australian market under the ticker PAR. Paradigm focuses on developing innovative therapies for various medical conditions.

Latest news from Paradigm Biopharmaceuticals Ltd.

Continuation of Suspension from Quotation

September 29, 2026

Continuation of Voluntary Suspension

September 27, 2026

Agreement to Return US$2M to Obsidian

September 24, 2026

Phase 3 Interim Result Below Continuation Threshold

September 23, 2026

Suspension from Quotation

September 22, 2026

All Paradigm Biopharmaceuticals Ltd. news →

Research Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. company profile

View the public company page for Paradigm Biopharmaceuticals Ltd. on 6ix.

Paradigm Biopharmaceuticals Ltd. news

Read company news and market updates connected to Paradigm Biopharmaceuticals Ltd..

Paradigm Biopharmaceuticals Ltd. investor events

Find investor webinars, events, and replay context for Paradigm Biopharmaceuticals Ltd..